European Commission HTA Proposals Should Mandate Comparative Trials, Says Germany

 
• By Francesca Bruce

Pharmaceutical companies should be obliged to carry out comparative trials, according to analysis from Germany’s Institute For Quality and Efficiency in Healthcare, IQWiG.

Render illustration of Clinical Trial title on medical documents
German HTA Suggests Making Comparative Trials Mandatory • Source: Shutterstock

More from Health Technology Assessment

More from Market Access